TABLE 2.
BMI and inflammatory markers of mothers with very low milk production, moderate milk production, and controls1
Milk production groups2 | ||||
---|---|---|---|---|
VL (n = 23) | MOD (n = 20) | Control (n = 18) | P value | |
BMI,3 kg/m2 | 39.6 [31.3–41.8]a | 29.0 [25.3–31.2]b | 26.1 [21.6–28.2]b | <0.001 |
Obesity, % BMI ≥ 30 kg/m2 | 78 | 40 | 22 | 0.003 |
Inflammatory markers | ||||
Serum hsCRP,4 % >5 mg/L | 57 | 15 | 17 | 0.004 |
Serum TNF-α,5 pg/mL | 6.3 [5.8–7.0] | 6.1 [5.7–6.7] | 5.8 [5.3–6.5] | 0.31 |
Milk TNF-α,6 % detected | 67 | 32 | 33 | 0.04 |
Milk TNF-α concentration of detected samples,7 pg/mL | 1.60 [0.88–2.13] | 0.98 [0.77–2.49] | 1.11 [0.70–1.42] | N/A |
Values are median [IQR] or percentages. Group differences were analyzed by nonparametric Kruskal–Wallis rank sum tests. Group median values in a row with different letters were significantly different (P < 0.05). Proportional differences were assessed by Pearson chi-square test. CRP, C-reactive protein; hsCRP, high-sensitivity CRP; MOD, moderate milk production group; VL, very low milk production group.
Milk production groups were defined as VL (<300 mL/d), MOD (≥300 mL/d), and control (externally recruited controls who were exclusively breastfeeding infants with healthy weight gain).
BMI measured at the baseline time point for VL and MOD groups.
Serum samples were unavailable for 2 participants: VL, n = 21; MOD, n = 20; control, n = 18.
One outlier of serum TNF-α > 20 pg/mL was removed for this analysis: VL, n = 23; MOD, n = 19; control, n = 18.
Milk samples were unavailable for TNF-α analysis for 3 participants: VL, n = 21; MOD, n = 19; control, n = 18. The lower limit of detection was 0.5 pg/mL.
Milk TNF-α concentrations are provided for the samples with a detectable value (>0.5 pg/mL): VL, n = 14; MOD, n = 6; control, n = 6.